Xiaobin Wu

2018

In 2018, Xiaobin Wu earned a total compensation of $21.5M as General Manager of China and President at BeiGene, Ltd..

Compensation breakdown

Non-Equity Incentive Plan$261,956
Option Awards$5,767,876
Salary$380,944
Stock Awards$14,999,860
Other$138,483
Total$21,549,119

Wu received $15M in stock awards, accounting for 70% of the total pay in 2018.

Wu also received $262K in non-equity incentive plan, $5.8M in option awards, $380.9K in salary and $138.5K in other compensation.

Rankings

In 2018, Xiaobin Wu's compensation ranked 128th out of 14,244 executives tracked by ExecPay. In other words, Wu earned more than 99.1% of executives.

ClassificationRankingPercentile
All
128
out of 14,244
99th
Division
Manufacturing
41
out of 5,765
99th
Major group
Chemicals And Allied Products
14
out of 2,128
99th
Industry group
Drugs
12
out of 1,817
99th
Industry
Pharmaceutical Preparations
6
out of 1,391
100th
Source: SEC filing on April 29, 2019.

Wu's colleagues

We found five more compensation records of executives who worked with Xiaobin Wu at BeiGene, Ltd. in 2018.

2018

John Oyler

BeiGene, Ltd.

Chief Executive Officer

2018

Howard Liang

BeiGene, Ltd.

Chief Financial Officer

2018

Jane Huang

BeiGene, Ltd.

Chief Medical Officer

2018

Amy Peterson

BeiGene, Ltd.

Chief Medical Officer

2018

Hematology Peterson

BeiGene, Ltd.

Chief Medical Officer

News

You may also like